This week in Paul's first video for Bold Profits Daily, he explains why the biotech sector is about to take off, and how best to profit from it. Investors in Celgene made 30% overnight when the company was acquired last week by Bristol-Myers Squibb. This wasn't the only acquisiton in the sector this past month. Additionally, Wall Street has been able to sell 51 IPOs to investors despite weary market conditions. Such activity indicates the big money wants to play into this industry. Subscribe to Bold Profits Daily and learn more about this trend at https://banyanhill.com/massive-rally-biotech-sector-2019/ About Paul Mampilly: Paul Mampilly is an American investor and former hedge fund manager. Paul has been featured on CNBC, Fox Business News and Bloomberg TV. He is the founder of the popular investment newsletter Profits Unlimited, where he uses his skills, experience and knowledge as a former Wall Street insider to guide his more than 130,000 subscribers into stocks that are primed to shoot higher. Paul’s Services: Profits Unlimited: https://pro.banyanhill.com/m/1134028 True Momentum: https://pro.banyanhill.com/m/1134032 Follow Paul Mampilly on Social Media! Twitter: http://twitter.com/MampillyGuru Facebook: https://www.facebook.com/PaulMampillyGuru Check out Paul’s blog and recommended investment resources at https://paulmampillyguru.com/ Like the info in this video? Comment below and let us know! Additionally, we love suggestions for new video topics, so feel free to share what you’d like to hear in future videos!